Eli Lilly and Company
LLY
$733.51
$8.641.19%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -16.08% | -17.32% | 14.16% | -7.22% | 11.88% |
| Total Depreciation and Amortization | 0.32% | -4.93% | -9.06% | -11.26% | -1.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 391.70% | 301.82% | -180.09% | -142.27% | -115.67% |
| Change in Net Operating Assets | -381,775.00% | -302.64% | 54.01% | 120.71% | 99.92% |
| Cash from Operations | -44.10% | -23.08% | -16.71% | -15.99% | 4.48% |
| Capital Expenditure | -85.92% | -74.94% | -85.01% | -56.91% | -41.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -219.16% | -- | -- | -- | 56.22% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -68.26% | -26.63% | 86.96% | 18.57% | -124.28% |
| Cash from Investing | -90.08% | -61.70% | -6.54% | -35.67% | -36.22% |
| Total Debt Issued | 477.43% | 118.93% | -22.91% | 70.31% | -37.86% |
| Total Debt Repaid | 100.00% | 100.00% | 56.82% | 10.24% | 18.30% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 50.00% | 66.67% | 66.67% | 72.73% | -20.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -15.09% | -14.92% | -14.75% | -14.70% | -14.55% |
| Other Financing Activities | -8.45% | -7.20% | -8.38% | -3.05% | -4.39% |
| Cash from Financing | 164.65% | 79.45% | 39.38% | 64.44% | -30.87% |
| Foreign Exchange rate Adjustments | 200.60% | 65.82% | 59.23% | -8.96% | 18.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.91% | 79.79% | 111.99% | 300.06% | -1,185.19% |
